A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...
Epidemiologic patterns and mortality outcomes in young lung cancer non-smokers: A National Inpatient Sample analysis (2016–2021).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results